Microalbuminuria and macrovascular risk factors in insulin-dependent diabetics;MICROALBUMINURIA Y FACTORES DE RIESGO MACROVASCULAR EN NINOS DIABETICOS INSULINO-DEPENDIENTES

Revista de Investigacion Clinica

Volumn 48, Issue 1, 1996, Pages 19-25

  Bravo Ríos, Luz Elena ^a,b   Cardoso Saldaña, Guillermo ^b   Torres Tamayo, Margarita ^a   Lerman Garber, Israel ^c   Zamora González, José ^b   García Bulnes, Guadalupe ^d   Mendoza Morfín, Fernando ^a   Posadas Romero, Carlos ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

coronary risk factors; insulin dependent diabetes mellitus; microalbuminuria

Indexed keywords

INSULIN;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; CHILD; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PROTEINURIA; RISK FACTOR; SEX DIFFERENCE;

ADOLESCENT; ALBUMINURIA; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; PREVALENCE; RISK FACTORS;

EID: 0029928906     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. De Fronzo RA. Nephropathy En: Lebovitz HE, ed. Therapy for diabetes mellitus and related disorders. Alexandria VA: American Diabetes Association, 1991:248-60.
2. Haffner SM, Fong D, Stern MP, Pugh JA, Hazuda HP, Patterson JK, et al. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes 1988;37:878-84.
3. Paisey RB, Arredondo G, Villalobos A, Lozano O, Guevara L, Kelly S. Association of differing dietary, metabolic and clinical risk factors with complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. Diabetes Care 1984;7:421-33.
4. Lopez-Uriarte A, Estrada VM. Causas de insuficiencia renal crónica y sus implicaciones terapéuticas. Rev Med IMSS 1983;21:507-15.
5. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311:89-93.
6. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987;31:673-89.
7. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. Diabetes 1983;32(suppl 2): 64-78.
8. Roe TF, Costin G, Kaufman FR, Carlson ME. Blood glucose control and albuminuria in type 1 diabetes mellitus. J Pediatr 1991; 119:178-82.
9. Krolewski AS, Canessa M, Warram JH, Laffel LMB, Chistlieb AR, Knowler WC, et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988;318:140-5.
10. Reddi AS, Camerini-Davalos RA. Diabetic nephropathy. Arch Intern Med 1990;150:31-43.
11. Salas M, Loredo A, Ramírez JA, Alvarez PA, Legorreta J. Guía para el diagnóstico y terapéutica en pediatría. México: Prensa Médica Mexicana, 1981:182.
12. De Long DA, De Long ER, Weed PD. A comparision of methods for the estimation of plasma low and very low density lipoprotein cholesterol. JAMA 1986;286:2372-7.
13. Warnick GR, Benderson JM, Albers JJ. Dextran-sulfate-Mg precipitation for quantification of high-density-lipoprotein cholesterol. Clin Chern 1982;28:1379-88.
14. Posadas-Romero C, Sepúlveda J, Tapia-Conyer R, Magos C, Cardoso Saldaña G, Zamora-González J, et al. Valores de colesterol sérico en la población mexicana. Sal Publ Mex 1992;34:157-67.
15. Stein EA. Guidelines and methods for assesing pediatric hyperlipidemia. Curr Opin Lipidol 1992; 3:395-8.
16. Kwiterovich PO Jr. Diagnóstico y tratamiento de dislipoproteinemia familiar en niños y adolescentes. Clin Pediatr Nort Am 1990;6:1547-80.
17. Kinoch PAM, Lehmann H. Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purposes. Lancet 1977;2:16.
18. García-Bulnes G, González-Bárcena D, Ibarra A, Pérez-López A, Exaire JE. Un método inmunonefelométrico con rayo láser para la determinación de microalbuminuria. Nefrología 1994;XIV:341-4.
19. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985;9:85-95.
20. Orchard TJ, Dorman JS, Maser RE, Baker JD, Drash LA, Ellis D, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh epidemiology of diabetes complications study. Diabetes 1990;39:1116-24.
21. Viberti GC, Hill RD, Jarrett RJ, Argiropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;1:1430-2.
22. Mogensen E, Vestbo E, Poulsen PL, Christiansen C, Damsgaard EM, Eiskjaer H, et al. Microalbuminuria and other potential confounders. Diabetes Care 1995;18:572-81.
23. Mau Pedersen M, Christiansen JS, Pedersen EB, Mogensen CE. Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycaemic control. Clin Sci 1993;83:445-51.
24. Dahlquist G, Rudberg S. The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Paediatr Scand 1987;76:795-800.
25. Salardi S, Cacciari E, Pascucci MG, Giambiasi E, Tacconi M, Tazzari R, et al. Microalbuminuria in diabetic children and adolescents. Acta Paediatr Scand 1990;79:437-43.
26. Coonrod BA, Ellis D, Becker DJ, Bunker CH, Lloyd CE, Drash AL, et al. Predictors of microalbuminuria in individuals with IDDM. Diabetes Care 1993;16:1376-81.
27. Wiseman M, Viberti G, Mackintosh D, Jarret RJ, Keen H. Glycaemia, arterial pressure and microalbuminuria in type I (insulin-dependent) diabetes mellitus. Diabetologia 1984;26:401-5.
28. Microalbuminuria Collaborative Study Group. Microalbuminuria in type I diabetic patients. Prevalence and clinical characteristics. Diabetes Care 1992;15:495-501.
29. Viberti GC, Keen H. The patterns of proteinuria in diabetes mellitus. Diabetes 1987;36:556-65.
30. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.